Skip to main content

Ring Timothy M's Form 4 filing

Quest Diagnostics Inc (DGX) · filed Nov 2, 2022

Accession no.
0001022079-22-000152
Filed
Nov 2, 2022
Trade date
Nov 1, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $288.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ring Timothy MCIK 0001204666Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2022Common StockMOption exerciseAcquired+260$61.23+$15,919.824,193Direct
Nov 1, 2022Common StockMOption exerciseAcquired+1,371$60.79+$83,343.0925,564Direct
Nov 1, 2022Common StockMOption exerciseAcquired+369$62.01+$22,881.6925,933Direct
Nov 1, 2022Common StockSSaleDisposed−2,000$144.06−$288,12024,149Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 1, 2022Common StockMOption exerciseDisposed−260$61.23−$15,919.80Direct
Nov 1, 2022Common StockMOption exerciseDisposed−1,371$60.79−$83,343.090Direct
Nov 1, 2022Common StockMOption exerciseDisposed−369$62.01−$22,881.69972Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)